Bristol Myers Squibb Profit Soars, Raises Revenue Guidance
PositiveFinancial Markets

Bristol Myers Squibb has reported a significant profit increase of nearly $1 billion in the third quarter, driven by reduced costs and strong revenue growth from its newer drugs. This is an encouraging sign for the company and the pharmaceutical industry, as it highlights the potential of innovative treatments to boost financial performance and improve patient outcomes.
— Curated by the World Pulse Now AI Editorial System









